Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis
Open Access
- 1 August 1999
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 58 (8) , 488-492
- https://doi.org/10.1136/ard.58.8.488
Abstract
OBJECTIVE Urokinase type plasminogen activator (uPA) catalyses the formation of the proteolytic enzyme plasmin, which is involved in matrix degradation in the processes of tissue remodelling. Because of a surface bound uPA receptor (uPAR), expressed by some cell types (for example, macrophages, malignant cells and inflammatory activated synoviocytes), the action of uPA can be localised and intensified. uPAR seems to have a role in the mechanisms leading to invasive growth of malignant tissue and the rheumatoid pannus. uPAR may become cleaved at its cell surface anchor, thus forming a free soluble receptor (suPAR). suPAR is detectable in low but constant values in plasma of healthy people, while increased concentrations are found in patients with disseminated malignant disease, so that suPAR may be an indicator of invasive growth and tissue remodelling. suPAR concentrations in plasma have not previously been measured in rheumatic patients. A controlled cross sectional measurement was performed of suPAR in plasma of patients with various inflammatory rheumatic disorders with special reference to rheumatoid arthritis (RA). METHODS suPAR in plasma was measured by ELISA technique in patients with RA (n=51), reactive arthritis (ReA) (n=23), primary Sjögren’s syndrome (PSS) (n=42) and sex and age matched healthy controls (n=53). RESULTS In the control group suPAR (median) was 0.91 (range 0.56–1.94) μg/l. Median suPAR value in RA was 1.47 (range 0.65–6.62) μg/l; in ReA 0.68 μg/l (range 0.52–1.48) and in PSS 1.12 μg/l (range 0.76–1.92); p versus controls CONCLUSIONS Increased suPAR concentrations were found in plasma in RA, and to a smaller extent also in PSS, but not in ReA. In RA suPAR is related to disease activity. suPAR seems though not merely to be an acute phase reactant like CRP. Increased suPAR values might reflect erosive activity in RA.Keywords
This publication has 28 references indexed in Scilit:
- Exacerbation of antigen-induced arthritis in urokinase-deficient mice.Journal of Clinical Investigation, 1998
- Urokinase in rheumatoid arthritis: causal or coincidental?Annals of the Rheumatic Diseases, 1997
- Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.Journal of Clinical Pathology, 1997
- DIFFERENCE IN EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN SYNOVIAL TISSUE OF PATIENTS WITH RHEUMATOID ARTHRITIS AND OSTEOARTHRITISRheumatology, 1996
- The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 1995
- Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseasesArthritis & Rheumatism, 1992
- Pathways of coagulation activation in situ in rheumatoid synovial tissueClinical Immunology and Immunopathology, 1992
- Increased proteolytic activity on the surface of monocytes from patients with rheumatoid arthritisArthritis & Rheumatism, 1991
- Effects of tumor necrosis factor α and β on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytesArthritis & Rheumatism, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988